Our Mission Statement

The International Castlemans Disease Organization is a non-profit institution committed to promoting the health of patients through advocacy, education, leadership, research, and service. This advocacy commitment is conducted through patient referrals to quality 'centers of excellence' where healthcare professionals and scientists research this rare disease for a comprehensive healthcare / treatment program.
New Clinical Studies PDF Print E-mail
Monday, 14 December 2009 22:06

A clinical trial has recently been launched to study an investigational medicine for patients with multicentric Castleman's disease (MCD). While the study will soon be open to patients in countries around the world, it is currently only enrolling patients in the United States.  More information on this new study can be found at: www.castlemansresearch.com.